Skip to main content

Table 1 Variables of CHD risk equation used in model base case

From: Improvement of long-term risks of cardiovascular events associated with community-based disease management in Chinese patients of the Xinjiang autonomous region of China

  Male Female
Coefficient Coefficient
Age 0.07 0.07
SBP - optimal −0.51 −0.5
SBP – normal Reference Reference
SBP – high normal 0.21 −0.87
SBP – stage 1 hypertension 0.33 0.34
SBP – stage 2–4 hypertension 0.77 0.47
Total cholesterol < 160 mg/dL −0.51 0.18
Total cholesterol 160–199 mg/dL Reference Reference
Total cholesterol 200–239 mg/dL 0.07 0.13
Total cholesterol 240–279 mg/dL 0.32 0.14
Total cholesterol ≥ 280 mg/dL 0.52 1.67
HDL-C < 35 mg/dL −0.25 0.62
HDL-C 35–44 mg/dL 0.01 0.3
HDL-C 45–49 mg/dL Reference 0.08
HDL-C 50–59 mg/dL −0.07 Reference
HDL-C ≥ 60 mg/dL −0.4 −0.78
Diabetes (yes = 1, no = 0) 0.09 0.18
Smoking (yes = 1, no = 0) 0.62 − 0.95
Survival 0.9895 0.9961
  1. CHD coronary heart disease, HDL-C high-density lipoprotein cholesterol, SBP systolic blood pressure
  2. SBP optimal: ≤120 mmHg; SBP normal 120–130 mmHg; SBP high normal 130–140 mmHg; SBP stage 1 hypertension 140–160 mmHg; SBP stage 2–4 hypertension ≥160 mmHg